Technical Sustainability Report

Overview

The report presents Bal Pharma's first materiality assessment, guided by GRI Standards 2021, and describes its initial ESG integration. It reports that 63% of total energy consumption came from renewable sources and quantifies Scope 1, Scope 2, and Scope 3 emissions. The company reports 977 permanent employees, women representing 9.4% of the workforce, and zero employee and contractor fatalities.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024-2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services